{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-008489","form_type":"8-K","ticker":"OGEN","cik":"0001174940","company_name":"ORAGENICS INC","filed_at":"2024-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.566079+00:00","generated_at":"2026-06-05T05:18:09.280737+00:00","sec_items":["1.01","3.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Oragenics closes $2.1M public offering of 1.4M shares; funds ONP-002 development","bullets":["Issued 1,400,000 shares at $1.50/share for gross proceeds of $2.1M.","Underwriters granted a 45-day option for up to 210,000 additional shares.","Net proceeds to fund continued development of ONP-002 for concussion treatment.","Representative's warrants issued for up to 5% of Shares at $1.875/share."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-008489","json":"https://secwatch.observer/filing/0001493152-24-008489.json","markdown":"https://secwatch.observer/filing/0001493152-24-008489.md","text":"https://secwatch.observer/filing/0001493152-24-008489.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224008489/0001493152-24-008489-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224008489/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T05:18:09.280737+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cf6de3a0e263a0c2f5fb660f6506e379a4f57067","claim":"ORAGENICS INC entered into Underwriting Agreement with ThinkEquity LLC valued at $2.1 million (effective 2024-02-27).","evidence_excerpt":"On February 27, 2024, Oragenics, Inc. (“Oragenics” or the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with ThinkEquity LLC, as representative (the “Representative”) of the underwriters named therein (collectively, the “Underwriters”), relating to the issuance and sale (the “Offering”) of 1,400,000 shares of the Company’s common stock at a price to the public of $1.50 per share (the “Underwritten Shares”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224008489/0001493152-24-008489-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"ThinkEquity LLC"},{"label":"Value","value":"$2.1 million"},{"label":"Effective","value":"2024-02-27"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}